Open AccessRomiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids
Author(s) -
Casanovas Taltavull Teresa,
PeñaCala Maria Carmen
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.667
Subject(s) - medicine , romiplostim , splenectomy , refractory (planetary science) , immune thrombocytopenia , surgery , thrombopoietin , platelet , spleen , genetics , physics , stem cell , haematopoiesis , astrobiology , biology
Key Clinical Message Our case report discusses the usefulness of administering romiplostim as a second‐line treatment before splenectomy in a cirrhotic patient with immune thrombocytopenia who developed corticosteroid‐induced Cushing's syndrome. Corticosteroids were tapered and consequently withdrawn. The patient made a full recovery postsplenectomy.